Skip to main content

Table 1 Characteristics of the pulmonary sarcoidosis patients.

From: Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis

Pulmonary Sarcoidosis Stages

Patients (n)

Age, years

Sex

Race

Lymphocytic Alveolitis

Immuno-suppressive Therapy

   

Males

Females

African-Americans

White

Others

  

I

27

39 ± 8

17(63)

10(37)

9(34)

12(44)

6(22)

13(48)

5(18)

II

36

39 ± 11

15(42)

21(58)

12(34)

20(55)

4(11)

12(33)

3(8)

III

9

54 ± 10

2(22)

7(78)

3(33)

5(55)

1(12)

2(22)

0(0)

  1. Data are presented as mean ± SD or n (%), unless otherwise stated.